ROLE OF THROMBOPHILIC GENE VARIANTS IN ETIOPATHOGENESIS ISCHEMIC STROKE IN COVID-19

Authors

  • Ibodov Bekhzod Abdusattorovich
  • Alimkhodjaeva Parakhat Rustaovna
  • Boboev Qodirjon Tuxtaboevich
  • Tuychibaeva Nodira Miratalievna

Keywords:

ischemic stroke, MTHFR, MTRR, MTR, VEGF, hyperhomocysteinemia, endothelial dysfunction, HIF

Abstract

One of the severe complications of COVID-19 is ischemic stroke, which have tendency to occurring not only during the diseases, but even after recovery from COVID-19. Because of post-COVID syndrome, procoagulant and anticoagulant balance of some patients still have damaged and risk of possibility thrombosis is very high. One of the main reasons of this issue related to dysfunction genes which responsible for folate cycle (MTHFR, MTRR, MTR) and angiogenetic factor – VEGFA. Because of deficit or inadequately expression of the former genes may cause chronic endothelial dysfunction which aggravate in COVID-19 and the latter gene may cause deficiency of angiogenesis in ischemic zone, so increase possibility of ischemic stroke. Investigation polymorph genes in uzbek population which responsible for this issue, may help to investigate vulnerable individuals, hence with help of these information we can improve prevention or treatment in those individuals through specific method from ischemic stroke and also other complications in COVID-19.              

References

Kulyutcina E.R., Tatarchenko I.P., Levashova O.A., Denisova A.G., Drujinina T.A. The interrelationship of indices of hemocysteine and genetic polymorphisms conditioning disorders of folates metabolism in healthy population. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics) 2017; 62 (2): 82-87. (in Russ.). DOI: http://dx.doi. org/10.18821/0869-2084-2017-62-2-82-87.

Пащенков М.В., Хаитов М.Р. Иммунный ответ против эпидемических коронавирусов. Иммунология. 2020, 41 (1): 5–18. DOI: 10.33029/0206-4952-2020-41-1-5-18.

Головкин А. С., Кудрявцев И. В., Дмитриев А. В., Калини- на О. В. Фиброзные изменения сердечно-сосудистой и дыхательной систем после перенесенной COVID-19: вклад факторов иммунной системы и генетическая предрасположенность. Российский кардиологический журнал. 2020;25(10):4087. doi:10.15829/1560-4071-2020-4087.

Болдырева М.Н. Вирус SARS-CoV-2 и другие эпидемические коронавирусы: патогенетические и генетические факторы развития инфекций. Иммунология. 2020; 41 (3): 197–205. DOI: 10.33029/0206- 4952-2020-41-3-197-205

Костинов М.П. Иммунопатогенные свойства SARS-CoV-2 как основа для выбора патогенетической терапии. Иммунология. 2020; 41 (1): 83–91. DOI: 10.33029/0206-4952-2020-41-1-83-91

Йокота Ш., Куройва Е., Нишиока К. Новая коронавирусная болезнь (COVID-19) и «цитокиновый шторм». Перспективы эффективного лечения с точки зрения патофизиологии воспалительного процесса // Инфекционные болезни: новости, мнения, обучение. 2020. Т. 9, № 4. С. 13–25. DOI: https://doi.org/10.33029/2305-3496-2020-9-4-13-25

Adriana Fodor, Brandusa Tiperciuc, Cezar Login, Olga H. Orasan, Andrada L. Lazar, Cristina Buchman, Patricia Hanghicel, Adela Sitar-Taut, Ramona Suharoschi, Romana Vulturar, and Angela Cozma. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19—Mechanisms and Therapeutic Targets. Oxidative Medicine and Cellular Longevity Volume 2021, Article ID 8671713, 15 pages https://doi.org/10.1155/2021/8671713.

Wort SJ, Evans TW. The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull. 1999;55(1):30-48. doi: 10.1258/0007142991902286. PMID: 10695078.

Kanduc, D. From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry. Antibodies 2021, 10, 36. https://doi.org/10.3390/antib10040036.

Головкин А. С., Кудрявцев И. В., Дмитриев А. В., Калини- на О. В. Фиброзные изменения сердечно-сосудистой и дыхательной систем после перенесенной COVID-19: вклад факторов иммунной системы и генетическая предрасположенность. Российский кардиологический журнал. 2020;25(10):4087. doi:10.15829/1560-4071-2020-4087.

Болдырева М.Н. Вирус SARS-CoV-2 и другие эпидемические коронавирусы: патогенетические и генетические факторы развития инфекций. Иммунология. 2020; 41 (3): 197–205. DOI: 10.33029/0206- 4952-2020-41-3-197-205.

Йокота Ш., Куройва Е., Нишиока К. Новая коронавирусная болезнь (COVID-19) и «цитокиновый шторм». Перспективы эффективного лечения с точки зрения патофизиологии воспалительного процесса // Инфекционные болезни: новости, мнения, обучение. 2020. Т. 9, № 4. С. 13–25. DOI: https://doi.org/10.33029/2305-3496-2020-9-4-13-25.

Sánchez-Zuno GA, Matuz-Flores MG, González-Estevez G, et al. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies. International Journal of Immunopathology and Pharmacology. January 2021. doi:10.1177/20587384211050199

Zhang J, Tecson KM, McCullough PA. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med. 2020 Sep 30;21(3):315-319. doi: 10.31083/j.rcm.2020.03.126. PMID: 33070537.

Zhang, S., Zhang, J., Wang, C., Chen, X., Zhao, X., Jing, H., Liu, H., Li, Z., Wang, L., & Shi, J. (2021). COVID 19 and ischemic stroke: Mechanisms of hypercoagulability (Review). International journal of molecular medicine, 47(3), 21. https://doi.org/10.3892/ijmm.2021.4854.

Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Raju M, Lobanova I, Suri MFK, Naqvi SH, French BR, Siddiq F, Gomez CR, Shyu CR. Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients. Stroke. 2021 Mar;52(3):905-912. doi: 10.1161/STROKEAHA.120.031786. Epub 2021 Feb 4. PMID: 33535779; PMCID: PMC7903982.

A.M. Jurayev, R.J. Khalimov New methods for surgical Treatment of Perthes disease in children International Journal of Psychosocial Rehabilitation, Vol 24, Issue 02, 2020 ISSN: 1475 -7192. 301-307.

Brandalize AP, Bandinelli E, Borba JB, Félix TM, Roisenberg I, Schüler-Faccini L. Polymorphisms in genes MTHFR, MTR and MTRR are not risk factors for cleft lip/palate in South Brazil. Braz J Med Biol Res. 2007 Jun;40(6):787-91. doi: 10.1590/s0100-879x2006005000112. PMID: 17581676.

Kurzawski M, Wajda A, Malinowski D, Kazienko A, Kurzawa R, Drozdzik M. Association study of folate-related enzymes (MTHFR, MTR, MTRR) genetic variants with non-obstructive male infertility in a Polish population. Genet Mol Biol. 2015;38(1):42-47. doi:10.1590/S1415-475738120140179.

Баканова М.Л., Минина В.И., Савченко Я.А., Глушков А.Н. Полиморфные варианты генов фолатного цикла у больных раком легкого. Сибирский онкологический журнал. 2019; 18 (2): 70–77. – doi: 10.21294/1814- 4861-2019-18-2-70-77.

Tretyakova T.B., Demchenko N.S. Association between polymorphic genes of folate metabolism and early pregnancy losses. Obstetrics, gynecology and reproduction [Akusherstvo, ginekologiya i reproduktsiya]. 2018; 12 (1): 42-52 (in Russian). DOI: 10.17749/2313-7347.2018.12.1.042-052.

А.С. Добролюбов, М.А. Липин, А.В.Поляков, И.Н. Фетисова. Полиморфизм Генов Фолатного Обмена И Болезни Человека. 2006; УДК: 616.1 + 618]: 575.191.

Voznjouk I.A., Ilyina O.M., Kolomentsev S.V. Ischemic Stroke as a Clinical Form and Pathogenetic Model in the Structure of Сentral Nervous System Lesions in COVID-19. Bulletin of Rehabilitation Medicine. 2020; 4 (98): 90–98. https://doi.org/10.38025/ 2078–1962–2020–98–4–90–98.

Attademo L, Bernardini F. Are dopamine and serotonin involved in COVID-19 pathophysiology?. Eur J Psychiatry. 2021;35(1):62-63. doi:10.1016/j.ejpsy.2020.10.004.

Raony Í, de Figueiredo CS, Pandolfo P, Giestal-de-Araujo E, Oliveira-Silva Bomfim P, Savino W. Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health. Front Immunol. 2020;11:1170. Published 2020 May 27. doi:10.3389/fimmu.2020.01170.

Rege, Sanil. (2021). COVID-19 and the Brain -Pathogenesis and Neuropsychiatric Manifestations of SARS-CoV-2 CNS Involvement.

Mahalakshmi AM, Ray B, Tuladhar S, Bhat A, Paneyala S, Patteswari D, Sakharkar MK, Hamdan H, Ojcius DM, Bolla SR, Essa MM, Chidambaram SB, Qoronfleh MW. Does COVID-19 contribute to development of neurological disease? Immun Inflamm Dis. 2021 Mar;9(1):48-58. doi: 10.1002/iid3.387. Epub 2020 Dec 17. PMID: 33332737; PMCID: PMC7860611.

Boldrini M, Canoll PD, Klein RS. How COVID-19 Affects the Brain. JAMA Psychiatry. 2021;78(6):682–683. doi:10.1001/jamapsychiatry.2021.0500.

Banerjee D, Viswanath B. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian J Psychiatr. 2020;54:102350. doi:10.1016/j.ajp.2020.102350.

Steardo L Jr, Steardo L, Verkhratsky A. Psychiatric face of COVID-19. Transl Psychiatry. 2020 Jul 30;10(1):261. doi: 10.1038/s41398-020-00949-5. PMID: 32732883; PMCID: PMC7391235.

Published

2022-02-26